San Francisco, California, March 23, 2021—Wave 80 Biosciences today announced a major expansion of its IP portfolio with the issuance of U.S. Patent 10,955,067, Methods and Systems for Enhanced [...]
Dr. Daniel Laser, Wave 80’s Chief Executive Officer and President, will discuss major recent advances in the company’s bioassay technology as part of an invited talk at the upcoming Semicon [...]
Dr. Laura Mazzola, Wave 80’s Senior Vice President of Global Initiatives, co-authors analysis of impact and opportunities for new diagnostics technologies.
Talk will highlight evolving challenges and opportunities in global health
With NIH support, initiative seeks to develop innovative new molecular diagnostics tools for guiding vaccine development and antiretroviral therapy
